Directory
>
Christopher Koth
Christopher Koth
Postdoctoral Fellow | Denali Therapeutics
California, South San Francisco, United States
Christopher Koth
Summary
Christopher Koth is a seasoned professional in the field of structural biology and drug discovery, currently serving as the Head of Biotherapeutics at Denali Therapeutics. With a strong background in membrane proteins and extensive experience in leading drug discovery projects, he has contributed significantly to the development of technologies for high-throughput screening and production. His academic journey culminated in a PhD from the University of Toronto, where he pioneered work on membrane protein structural genomics. Christopher has held various leadership roles at prominent organizations such as Genentech and Vertex Pharmaceuticals, showcasing his ability to drive innovation and cross-functional collaboration. He is passionate about advancing therapeutic solutions for infectious diseases and optimizing drug discovery processes. His work has led to multiple publications in prestigious journals, highlighting his expertise in structural insights into biological processes. Outside of his professional life, Christopher is likely to be engaged in initiatives that bridge science and technology with practical applications in healthcare.
Christopher Koth
Work Experience
Vice President, Biotherapeutics at
Denali Therapeutics
November 2023 - Present
Christopher Koth
Education
University of Toronto, PhD, Structural and Molecular Biology
January 1996 - January 2002
Frequently Asked Questions about Christopher Koth
What is Christopher Koth email address?
Christopher Koth's primary email address is *****@denalitherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Christopher Koth work for?
Christopher Koth is a Postdoctoral Fellow at Denali Therapeutics.
Where Christopher Koth graduated from?
Christopher Koth holds a degree in null from University of Toronto.
How can I directly contact Christopher Koth?
To contact Christopher Koth directly, you can use the email address *****@denalitherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Christopher Koth?
Christopher Koth is a seasoned professional in the field of structural biology and drug discovery, currently serving as the Head of Biotherapeutics at Denali Therapeutics. With a strong background in membrane proteins and extensive experience in leading drug discovery projects, he has contributed significantly to the development of technologies for high-throughput screening and production. His academic journey culminated in a PhD from the University of Toronto, where he pioneered work on membrane protein structural genomics. Christopher has held various leadership roles at prominent organizations such as Genentech and Vertex Pharmaceuticals, showcasing his ability to drive innovation and cross-functional collaboration. He is passionate about advancing therapeutic solutions for infectious diseases and optimizing drug discovery processes. His work has led to multiple publications in prestigious journals, highlighting his expertise in structural insights into biological processes. Outside of his professional life, Christopher is likely to be engaged in initiatives that bridge science and technology with practical applications in healthcare.
Christopher`s contact details
*****@denalitherapeutics.com
Colleagues
Movement Disorders Fellow
Staff Research Associate II
Research Associate
Sr. Associate Scientist
Technical Operations Process Engineer
Investment Banking Associate
Research Chemist
Assistant Manager
Senior Director, Corporate Development
Marine, Staff Sergeant